Imbdx Inc. (461030)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
3,610. 00
+235
+6.963%
₩
93.36B Market Cap
- P/E Ratio
- Div Yield
24,343 Volume
- Eps
₩ 3,375
Previous Close Want to track 461030 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
461030 closed today higher at ₩3,610, an increase of 6.963% from yesterday's close, completing a monthly increase of 1.5471% or ₩55. Over the past 12 months, 461030 stock lost -63.9%.
461030 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
Imbdx Inc. (461030) FAQ
What is the stock price today?
The current price is ₩3,610.00.
On which exchange is it traded?
Imbdx Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 461030.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 93.36B.
Has Imbdx Inc. ever had a stock split?
No, there has never been a stock split.
Imbdx Inc. Profile
| Professional Services Industry | Industrials Sector | Mr. Tae-You Kim M.D., Ph.D. CEO | KRX SM Exchange | KR7461030009 ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Imbdx Inc. is a cutting-edge biotechnology company that specializes in developing innovative diagnostic solutions for cancer detection. Their primary function is to improve early cancer diagnosis through advanced molecular diagnostics and liquid biopsy technologies. By focusing on these areas, Imbdx Inc. significantly impacts the healthcare sector, particularly the precision medicine and oncology fields. The company’s technologies aim to enhance the accuracy of cancer diagnosis, offering early detection possibilities that are crucial for effective treatment outcomes. Imbdx Inc. plays a vital role in the biotechnology market, continuously advancing the development of non-invasive diagnostic solutions. Its efforts contribute to the broader goal of personalized healthcare, addressing some of the most pressing challenges in contemporary medicine.
Contact Information
Address: BYC Highcity Bldg A
Phone: 82 2 6951 2906
Website: https://www.imbdx.com
